
Overview
Kelly G. Ross, MD, specializes in hematology oncology and is board-certified in hematolgoy and medical oncology by the American Board of Internal Medicine. She is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Ross completed her fellowship at the University of Colorado and residency and medical degree at the University of Pittsburgh School of Medicine.
Dr. Ross is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant.
Dr. Ross is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 3 clinical trials. Dr. Ross is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- MEDICARE PDP
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
UPMC Hillman Cancer Center
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is highly rated in 41 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery. Dr. Burgess is board certified in American Board Of Internal Medicine. Dr. Burgess is currently accepting new patients.
UPMC Hillman Cancer Center
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center.Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy. Dr. Brufsky is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Brufsky is currently accepting new patients.
UPMC Hillman Cancer Center
Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Villaruz is board certified in American Board Of Internal Medicine. Dr. Villaruz is currently accepting new patients.
Frequently Asked Questions about Dr. Kelly G. Ross
How do I make an appointment with Dr. Kelly G. Ross?
You can book an appointment with Dr. Kelly G. Ross by calling their office at 412-569-8879. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Kelly G. Ross a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kelly G. Ross is classified as an Distinguished expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Kelly G. Ross specialize in?
While Dr. Kelly G. Ross is a Hematology Oncology, they have specific expertise in Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Mantle Cell Lymphoma (MCL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Kelly G. Ross participate in research or clinical trials?
Yes. Dr. Kelly G. Ross has published 13 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. Kelly G. Ross's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Kelly G. Ross accept my insurance?
Dr. Kelly G. Ross accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 412-569-8879 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Ross isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Mantle Cell Lymphoma (MCL)Dr. Ross isDistinguished. Learn about Mantle Cell Lymphoma (MCL).
- Multiple MyelomaDr. Ross isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloblastic Leukemia with Maturation
- B-Cell LymphomaDr. Ross isAdvanced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Ross isAdvanced. Learn about Bone Marrow Aspiration.
- Childhood Acute Myeloid Leukemia
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)
- Classical Hodgkin LymphomaDr. Ross isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Gastric LymphomaDr. Ross isAdvanced. Learn about Gastric Lymphoma.
- Hodgkin LymphomaDr. Ross isAdvanced. Learn about Hodgkin Lymphoma.
- Langerhans Cell HistiocytosisDr. Ross isAdvanced. Learn about Langerhans Cell Histiocytosis.
- Large-Cell Immunoblastic Lymphoma
- Non-Hodgkin LymphomaDr. Ross isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Richter SyndromeDr. Ross isAdvanced. Learn about Richter Syndrome.
- Smoldering Multiple MyelomaDr. Ross isAdvanced. Learn about Smoldering Multiple Myeloma.
- Experienced
- Acute Monoblastic Leukemia (AmoL)Dr. Ross isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Promyelocytic LeukemiaDr. Ross isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult T-Cell LeukemiaDr. Ross isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Ross isExperienced. Learn about Agranulocytosis.
- Aleukemic Leukemia Cutis (ALC)Dr. Ross isExperienced. Learn about Aleukemic Leukemia Cutis (ALC).
- Ataxia-Pancytopenia SyndromeDr. Ross isExperienced. Learn about Ataxia-Pancytopenia Syndrome.
- Bone Marrow TransplantDr. Ross isExperienced. Learn about Bone Marrow Transplant.
- Burkitt LymphomaDr. Ross isExperienced. Learn about Burkitt Lymphoma.
- Castleman DiseaseDr. Ross isExperienced. Learn about Castleman Disease.
- Chronic Familial NeutropeniaDr. Ross isExperienced. Learn about Chronic Familial Neutropenia.
- Chronic Graft Versus Host Disease (cGvHD)
- Chronic Myelomonocytic Leukemia (CMML)
- Chronic T-Cell Leukemia (CTCL)Dr. Ross isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Ross isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Essential ThrombocythemiaDr. Ross isExperienced. Learn about Essential Thrombocythemia.
- Fanconi AnemiaDr. Ross isExperienced. Learn about Fanconi Anemia.
- Febrile NeutropeniaDr. Ross isExperienced. Learn about Febrile Neutropenia.
- Follicular LymphomaDr. Ross isExperienced. Learn about Follicular Lymphoma.
- Graft Versus Host Disease (GvHD)Dr. Ross isExperienced. Learn about Graft Versus Host Disease (GvHD).
- LeukemiaDr. Ross isExperienced. Learn about Leukemia.
- Marginal Zone Lymphoma (MZL)Dr. Ross isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Midline Lethal GranulomaDr. Ross isExperienced. Learn about Midline Lethal Granuloma.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multicentric Castleman Disease (MCD)
- Mycosis FungoidesDr. Ross isExperienced. Learn about Mycosis Fungoides.
- Myelodysplastic Syndrome (MDS)Dr. Ross isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- MyelofibrosisDr. Ross isExperienced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Dr. Ross isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- PlasmacytomaDr. Ross isExperienced. Learn about Plasmacytoma.
- Polycythemia VeraDr. Ross isExperienced. Learn about Polycythemia Vera.
- Primary AmyloidosisDr. Ross isExperienced. Learn about Primary Amyloidosis.
- Primary Lymphoma of the BrainDr. Ross isExperienced. Learn about Primary Lymphoma of the Brain.
- Pure Red Cell AplasiaDr. Ross isExperienced. Learn about Pure Red Cell Aplasia.
- Relapsed Refractory Multiple Myeloma (RRMM)
- Renal Hypomagnesemia Type 2Dr. Ross isExperienced. Learn about Renal Hypomagnesemia Type 2.
- Schnitzler SyndromeDr. Ross isExperienced. Learn about Schnitzler Syndrome.
- Shwachman-Diamond SyndromeDr. Ross isExperienced. Learn about Shwachman-Diamond Syndrome.
- Small Lymphocytic Lymphoma (SLL)Dr. Ross isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).
- T-Cell LymphomaDr. Ross isExperienced. Learn about T-Cell Lymphoma.
- Unicentric Castleman Disease (UCD)Dr. Ross isExperienced. Learn about Unicentric Castleman Disease (UCD).
- Waldenstrom MacroglobulinemiaDr. Ross isExperienced. Learn about Waldenstrom Macroglobulinemia.


